Scopus Biopharma Inc

General ticker "SCPS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $11.5K

Scopus Biopharma Inc does not follow the US Stock Market performance with the rate: -29.8%.

Estimated limits based on current volatility of -0.4%: low 0.00$, high 0.00$

Factors to consider:

  • Current price 99.6% below estimated low
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [0.09$, 0.39$]
  • 2023-12-31 to 2024-12-30 estimated range: [0.09$, 0.36$]

Financial Metrics affecting the SCPS estimates:

  • Negative: Non-GAAP EPS, $ of -0.55 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -66.70 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -21.66 <= 3.85
  • Negative: Industry operating profit margin (median), % of -98.17 <= 2.14

Similar symbols

Short-term SCPS quotes

Long-term SCPS plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $10.16MM $27.63MM $11.71MM
Operating Income $-10.16MM $-27.63MM $-11.71MM
Non-Operating Income $-0.71MM $1.36MM $0.00MM
Interest Expense $0.71MM $0.77MM $0.00MM
R&D Expense $7.42MM $15.02MM $2.68MM
Income(Loss) $-10.86MM $-26.27MM $-11.71MM
Profit(Loss) $-10.86MM $-26.27MM $-11.71MM
Stockholders Equity $-1.83MM $4.02MM $-6.56MM
Assets $1.97MM $8.19MM $0.39MM
Operating Cash Flow $-2.53MM $-11.42MM $-8.13MM
Capital expenditure $0.00MM $0.00MM $0.00MM
Investing Cash Flow $-0.03MM $-0.02MM $0.07MM
Financing Cash Flow $4.35MM $17.56MM $0.24MM
Earnings Per Share* $-0.87 $-1.61 $-0.55

* EPS are Split Adjusted, recent splits may be reflected with a delay.